18 Drug Manufacturers - General issuers carry a screening verdict, out of 29 issuers we hold in this industry. Verdicts come from two independent engines and each row says which.
16 screened by our own engine against published ratio methodologies computed from primary filings · 3 carrying a reviewed third-party provider verdict.
Classified under Healthcare.
This industry is below the 25-issuer threshold for search indexing — the page is here, but it is not offered to crawlers as a landing page.
The seven standards HTR computes reach different verdicts on 14 of the 28 Drug Manufacturers - General issuers that more than one of them can decide — 50%.
A split is one issuer at least one standard passes and at least one fails. Why they disagree is mostly the denominator each standard measures debt against, not the ceiling.
Compliant first, then alphabetical. Every row links to that issuer's full ratio breakdown, business-activity screen and the filing behind it.
| Issuer | Verdict | Screened | Source |
|---|---|---|---|
| ABBV Abbvie Inc | COMPLIANT | 2026-09-07 | provider |
| ALPMY Astellas Pharma Inc. - ADR | COMPLIANT | 2026-09-07 | provider |
| 4519.T Chugai Pharmaceutical Co., Ltd. | COMPLIANT | 2026-08-28 | in-house |
| CMHC.SW Cosmo N.V. | COMPLIANT | 2026-08-27 | in-house |
| 4568.T Daiichi Sankyo Company, Limited | COMPLIANT | 2026-08-26 | in-house |
| GLAXO.NS GlaxoSmithKline Pharmaceuticals Limited | COMPLIANT | 2026-08-26 | in-house |
| KOPRAN.BO Kopran Limited | COMPLIANT | 2026-08-27 | in-house |
| MARKSANS.NS Marksans Pharma Limited | COMPLIANT | 2026-08-26 | in-house |
| NVO Novo Nordisk - ADR | COMPLIANT | 2026-09-07 | provider |
| RUBICON.NS Rubicon Research Limited | COMPLIANT | 2026-08-28 | in-house |
| SANOFICONR.NS Sanofi Consumer Healthcare India Limited | COMPLIANT | 2026-08-26 | in-house |
| 4536.T Santen Pharmaceutical Co., Ltd. | COMPLIANT | 2026-08-28 | in-house |
| SENORES.NS Senores Pharmaceuticals Limited | COMPLIANT | 2026-08-27 | in-house |
| SMSPHARMA.BO SMS Pharmaceuticals Limited | COMPLIANT | 2026-08-28 | in-house |
| 300181.SZ Zhejiang Jolly Pharmaceutical Co.,LTD | COMPLIANT | 2026-08-26 | in-house |
| 4882.T 4882.T | NO VERDICT | — | not screened yet |
| ALPMF ALPMF | NO VERDICT | — | not screened yet |
| AMRN Amarin Corporation plc | UNRATED | 2026-08-27 | in-house |
| BAYN.DE Bayer Aktiengesellschaft | NON-COMPLIANT | 2026-08-27 | in-house |
| CHGCF CHGCF | NO VERDICT | — | not screened yet |
| CHJTF CHJTF | NO VERDICT | — | not screened yet |
| CMOPF CMOPF | NO VERDICT | — | not screened yet |
| MIRA MIRA | NO VERDICT | — | not screened yet |
| NSRX NSRX | NO VERDICT | — | not screened yet |
| OPHLF OPHLF | NO VERDICT | — | not screened yet |
| OPHLY OPHLY | NO VERDICT | — | not screened yet |
| PFIZER.NS Pfizer Limited | NON-COMPLIANT | 2026-08-26 | in-house |
| SCLX SCLX | NO VERDICT | — | not screened yet |
| 000411.SZ Zhejiang Int'l Group Co.,Ltd. | NON-COMPLIANT | 2026-08-27 | in-house |